Resources Contact Us Home
Oligoadenylate synthetase (OAS)

Image Number 2 for United States Patent #8133710.

The invention describes novel pharmaceutical compositions for the treatment of virus infections and cancer. The pharmaceutical compositions include mutant oligoadenylate synthetases (OAS) that have either enhanced cell permeability, reduced oxidative potential, improved antiviral activity, improved enzymatic activity, or absent enzymatic activity. The pharmaceutical compositions have improved drug properties and retain or have enhanced antiviral activity relative to their native forms. The pharmaceutical compositions further include chemically modified oligoadenylate synthetases, such chemical modifications being designed to increase serum stability and reduce immunogenicity in vivo. Such chemical modifications further increase drug stability and manufacturability in vitro. Compositions composed of more than ninety novel modifications are described. Also described are antibodies to polypeptides of the invention.

  Recently Added Patents
Minimizing saturation caused by power transfer in a communication system transformer
Information descriptor and extended information descriptor data structures for digital television signals
Engine cover for motor vehicle
Lens apparatus and image pickup system including the same
Lighting apparatus
System and method for determining humidity in a respiratory treatment system
Method for temporal error concealment
  Randomly Featured Patents
Apparatus for transferring groups of disc-shaped objects
Microlens for surface mount products
Method and arrangement in a radio communication system
Portable orthopedic footstool
Air compressor cylinder housing
Composition and paper comprising cellulose ester, alkylpolyglycosides, and cellulose
Loader work machine
Wheel hub with lubrication fittings
Assay kit and antibody for human low molecular weight CD14
Flexible actuator